{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T12:34:17Z","timestamp":1773232457982,"version":"3.50.1"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019533","name":"Moderna Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019533","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jconrel.2025.114312","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:36:28Z","timestamp":1760196988000},"page":"114312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Surface-engineered robust hybrid lipid nanocapsules: A next-generation nanoplatform for mRNA delivery"],"prefix":"10.1016","volume":"388","author":[{"given":"Sunil Kumar","family":"Yadava","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuja","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mridula","family":"Kabilan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie A.","family":"Champion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus T.","family":"Cicerone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jconrel.2025.114312_bb0005","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1384","article-title":"mRNA vaccine in cancer therapy: current advance and future outlook","volume":"13","author":"Li","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114312_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113788","article-title":"Amplifying STING activation by biomimetic manganese mRNA nanovaccines for local and systemic cancer immunotherapy","volume":"383","author":"He","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114312_bb0015","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jconrel.2024.10.035","article-title":"Recent advances in mRNA-based cancer vaccines encoding immunostimulants and their delivery strategies","volume":"376","author":"Eslami","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114312_bb0020","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jconrel.2024.04.039","article-title":"Emerging advances in delivery systems for mRNA cancer vaccines","volume":"370","author":"Jiang","year":"2024","journal-title":"J. Control. Release"},{"issue":"34","key":"10.1016\/j.jconrel.2025.114312_bb0025","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2207841119","article-title":"Lipid nanoparticle-mediated lymph node\u2013targeting delivery of mRNA cancer vaccine elicits robust CD8+ T cell response","volume":"119","author":"Chen","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2025.114312_bb0030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.biomaterials.2017.02.019","article-title":"Lipopolyplex potentiates anti-tumor immunity of mRNA-based vaccination","volume":"125","author":"Persano","year":"2017","journal-title":"Biomaterials"},{"issue":"7823","key":"10.1016\/j.jconrel.2025.114312_bb0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41586-020-2537-9","article-title":"An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma","volume":"585","author":"Sahin","year":"2020","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.jconrel.2025.114312_bb0040","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41568-023-00586-2","article-title":"mRNA-based cancer therapeutics","volume":"23","author":"Liu","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114312_bb0045","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12943-023-01807-w","article-title":"The use of RNA-based treatments in the field of cancer immunotherapy","volume":"22","author":"Chehelgerdi","year":"2023","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.jconrel.2025.114312_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10492","article-title":"Nanomaterials for mRNA-based therapeutics: challenges and opportunities","volume":"8","author":"Li","year":"2023","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114312_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113676","article-title":"Incorporation of cellular membrane protein extracts into lipid nanoparticles enhances their cellular uptake and mRNA delivery efficiency","volume":"382","author":"Rodr\u00edguez","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114312_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113737","article-title":"Dimethylamino-based synthetic lipidoid nanoparticles for selective mRNA delivery to splenic antigen-presenting cells","volume":"382","author":"Liang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114312_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.02.056","article-title":"Advances in polymer nanomaterials targeting cGAS-STING pathway for enhanced cancer immunotherapy","volume":"381","author":"Peng","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114312_bb0070","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jconrel.2023.11.034","article-title":"Effective delivery of miR-511-3p with mannose-decorated exosomes with RNA nanoparticles confers protection against asthma","volume":"365","author":"Tu","year":"2024","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114312_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13010045","article-title":"Nanoparticles as adjuvants and Nanodelivery systems for mRNA-based vaccines","volume":"13","author":"Alfagih","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114312_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9010065","article-title":"Nanomaterial delivery systems for mRNA vaccines","volume":"9","author":"Buschmann","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.jconrel.2025.114312_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.589959","article-title":"Advances in lipid nanoparticles for mRNA-based Cancer immunotherapy","volume":"8","author":"Guevara","year":"2020","journal-title":"Front. Chem."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114312_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12020102","article-title":"Opportunities and challenges in the delivery of mRNA-based vaccines","volume":"12","author":"Wadhwa","year":"2020","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114312_bb0095","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","article-title":"Chemistry of lipid nanoparticles for RNA delivery","volume":"55","author":"Eygeris","year":"2022","journal-title":"Acc. Chem. Res."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114312_bb0100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/17425247.2023.2162876","article-title":"Why mRNA-ionizable LNPs formulations are so short-lived: causes and way-out","volume":"20","author":"De","year":"2023","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114312_bb0105","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0168-3659(02)00462-5","article-title":"Accelerated clearance of PEGylated liposomes in rats after repeated injections","volume":"88","author":"Ishida","year":"2003","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.jconrel.2025.114312_bb0110","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jconrel.2007.05.015","article-title":"PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner","volume":"122","author":"Ishida","year":"2007","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.jconrel.2025.114312_bb0115","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1021\/acs.bioconjchem.3c00174","article-title":"PEGylated lipid nanoparticle formulations: immunological safety and efficiency perspective","volume":"34","author":"Tenchov","year":"2023","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2025.114312_bb0120","article-title":"Mannich reaction-based combinatorial libraries identify antioxidant ionizable lipids for mRNA delivery with reduced immunogenicity","author":"Gong","year":"2025","journal-title":"Nat. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114312_bb0125","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1186\/s12951-024-02919-1","article-title":"High-throughput synthesis and optimization of ionizable lipids through A3 coupling for efficient mRNA delivery","volume":"22","author":"Li","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"13","key":"10.1016\/j.jconrel.2025.114312_bb0130","doi-asserted-by":"crossref","first-page":"15981","DOI":"10.1021\/acsami.4c00992","article-title":"Hybrid lipid Nanocapsules: a robust platform for mRNA delivery","volume":"16","author":"Yadava","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"5","key":"10.1016\/j.jconrel.2025.114312_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3415","article-title":"Histidine-enhanced gene delivery systems: the state of the art","volume":"24","author":"Hooshmand","year":"2022","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jconrel.2025.114312_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bej.2020.107526","article-title":"Self-assembled pH-responsive polymeric nanoparticles based on lignin-histidine conjugate with small particle size for efficient delivery of anti-tumor drugs","volume":"156","author":"Zhao","year":"2020","journal-title":"Biochem. Eng. J."},{"issue":"8","key":"10.1016\/j.jconrel.2025.114312_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12080774","article-title":"The multifaceted histidine-based carriers for nucleic acid delivery: advances and challenges","volume":"12","author":"He","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.114312_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111775","article-title":"Lipid nanocapsules co-encapsulating paclitaxel and salinomycin for eradicating breast cancer and cancer stem cells","volume":"204","author":"Basu","year":"2021","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.jconrel.2025.114312_bb0155","doi-asserted-by":"crossref","DOI":"10.1021\/acsabm.0c00764","article-title":"Curcumin-loaded nanostructure hybrid lipid capsules for co-eradication of breast Cancer and Cancer stem cells with enhanced anticancer efficacy","author":"Yadava","year":"2020","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.jconrel.2025.114312_bb0160","first-page":"51767","article-title":"A facile strategy for the preparation of polypropylene sulfide nanoparticles for hydrophobic and base-sensitive cargo","author":"Chauhan","year":"2025","journal-title":"J. Appl. Polymer Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114312_bb0165","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12951-019-0567-y","article-title":"Biological response and cytotoxicity induced by lipid nanocapsules","volume":"18","author":"Szwed","year":"2020","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.114312_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120217","article-title":"Mechanism of cellular uptake and cytotoxicity of paclitaxel loaded lipid nanocapsules in breast cancer cells","volume":"597","author":"Valsalakumari","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114312_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020346","article-title":"Deciphering the functional composition of Fusogenic liposomes","volume":"19","author":"Kola\u0161inac","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.114312_bb0180","first-page":"3197","article-title":"Dextran-b-poly(L-histidine) copolymer nanoparticles for ph-responsive drug delivery to tumor cells","volume":"8","author":"Hwang","year":"2013","journal-title":"Int. J. Nanomedicine"},{"issue":"9","key":"10.1016\/j.jconrel.2025.114312_bb0185","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/anie.201002969","article-title":"PEGylated inorganic nanoparticles","volume":"50","author":"Karakoti","year":"2011","journal-title":"Angew. Chem. Int. Ed."},{"issue":"12","key":"10.1016\/j.jconrel.2025.114312_bb0190","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/nnano.2012.207","article-title":"Biomolecular coronas provide the biological identity of nanosized materials","volume":"7","author":"Monopoli","year":"2012","journal-title":"Nature Nanotech"},{"issue":"Pt A","key":"10.1016\/j.jconrel.2025.114312_bb0195","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114312_bb0200","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.2147\/IJN.S36111","article-title":"The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles","volume":"7","author":"Fr\u00f6hlich","year":"2012","journal-title":"Int. J. Nanomed."},{"issue":"26","key":"10.1016\/j.jconrel.2025.114312_bb0205","doi-asserted-by":"crossref","first-page":"6867","DOI":"10.1016\/j.biomaterials.2010.05.027","article-title":"The systemic toxicity of positively charged lipid nanoparticles and the role of toll-like receptor 4 in immune activation","volume":"31","author":"Kedmi","year":"2010","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114312_bb0210","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.1038\/s41598-019-42225-7","article-title":"Impact of nanoparticle uptake on the biophysical properties of cell for biomedical engineering applications","volume":"9","author":"Rasel","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.114312_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2024.133800","article-title":"Beyond the promise: exploring the complex interactions of nanoparticles within biological systems","volume":"468","author":"Ji","year":"2024","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.jconrel.2025.114312_bb0220","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijpharm.2019.01.003","article-title":"Improved histidinylated lPEI polyplexes for skeletal muscle cells transfection","volume":"559","author":"Gomez","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114312_bb0225","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1078\/0171-9335-00363","article-title":"PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles","volume":"83","author":"Mishra","year":"2004","journal-title":"Eur. J. Cell Biol."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114312_bb0230","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.addr.2010.09.001","article-title":"A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma","volume":"63","author":"Hatakeyama","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2025.114312_bb0235","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ijpharm.2013.12.029","article-title":"Serum-resistant complex nanoparticles functionalized with imidazole-rich polypeptide for gene delivery to pulmonary metastatic melanoma","volume":"461","author":"Gu","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2025.114312_bb0240","first-page":"197","article-title":"Improved gene transfer with histidine-functionalized mesoporous silica nanoparticles","volume":"471","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114312_bb0245","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3390\/v16010120","article-title":"mRNA vaccine Nanoplatforms and innate immunity","volume":"16","author":"Wei","year":"2024","journal-title":"Viruses"},{"issue":"10","key":"10.1016\/j.jconrel.2025.114312_bb0250","doi-asserted-by":"crossref","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics \u2014 developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.jconrel.2025.114312_bb0255","doi-asserted-by":"crossref","first-page":"6996","DOI":"10.1021\/acsnano.5b01326","article-title":"Surface functionalization of nanoparticles with polyethylene glycol: effects on protein adsorption and cellular uptake","volume":"9","author":"Pelaz","year":"2015","journal-title":"ACS Nano"},{"issue":"8","key":"10.1016\/j.jconrel.2025.114312_bb0260","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nnano.2007.223","article-title":"Immunological properties of engineered nanomaterials","volume":"2","author":"Dobrovolskaia","year":"2007","journal-title":"Nature Nanotech"},{"key":"10.1016\/j.jconrel.2025.114312_bb0265","series-title":"Histidine-Enriched Multifunctional Peptide Vectors with Enhanced Cellular Uptake and Endosomal Escape for Gene Delivery","author":"Meng","year":"2016"},{"issue":"4","key":"10.1016\/j.jconrel.2025.114312_bb0270","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s40843-019-1231-y","article-title":"Endosomal escape of protein nanoparticles engineered through humanized histidine-rich peptides","volume":"63","author":"L\u00f3pez-Laguna","year":"2020","journal-title":"Sci. China Mater."},{"issue":"12","key":"10.1016\/j.jconrel.2025.114312_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103479","article-title":"The mRNA-LNP platform\u2019s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory","volume":"24","author":"Ndeupen","year":"2021","journal-title":"iScience"},{"issue":"2","key":"10.1016\/j.jconrel.2025.114312_bb0280","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.tox.2005.07.023","article-title":"Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity","volume":"216","author":"Szebeni","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.jconrel.2025.114312_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2023.103049","article-title":"Immune response to the components of lipid nanoparticles for ribonucleic acid therapeutics","volume":"85","author":"Chen","year":"2024","journal-title":"Curr. Opin. Biotechnol."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114312_bb0290","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41577-022-00825-x","article-title":"Impact of anti-PEG antibodies induced by SARS-CoV-2 mRNA vaccines","volume":"23","author":"Ju","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114312_bb0295","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jconrel.2006.08.001","article-title":"Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes","volume":"115","author":"Ishida","year":"2006","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114312_bb0300","first-page":"8","article-title":"The role of space charge formation in the generation of thermally stimulated current (TSC) spectroscopy data for a model amorphous drug system","volume":"353","author":"Antonijevi\u0107","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.jconrel.2025.114312_bb0305","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"54","author":"Alameh","year":"2021","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.jconrel.2025.114312_bb0310","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nnano.2015.330","article-title":"Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers","volume":"11","author":"Sch\u00f6ttler","year":"2016","journal-title":"Nature Nanotech"},{"key":"10.1016\/j.jconrel.2025.114312_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2024.102506","article-title":"Strategies and mechanisms for endosomal escape of therapeutic nucleic acids","volume":"81","author":"Grau","year":"2024","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"12","key":"10.1016\/j.jconrel.2025.114312_bb0320","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114312_bb0325","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.xphs.2022.11.001","article-title":"The storage and in-use stability of mRNA vaccines and therapeutics: not a cold case","volume":"112","author":"Oude Blenke","year":"2023","journal-title":"J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.jconrel.2025.114312_bb0330","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.ymthe.2022.02.001","article-title":"Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine","volume":"30","author":"Muramatsu","year":"2022","journal-title":"Mol. Ther."},{"issue":"7607","key":"10.1016\/j.jconrel.2025.114312_bb0335","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature18300","article-title":"Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy","volume":"534","author":"Kranz","year":"2016","journal-title":"Nature"},{"issue":"10427","key":"10.1016\/j.jconrel.2025.114312_bb0340","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(23)02268-7","article-title":"Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study","volume":"403","author":"Weber","year":"2024","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jconrel.2025.114312_bb0345","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jcf.2023.04.008","article-title":"Inhaled mRNA therapy for treatment of cystic fibrosis: interim results of a randomized, double-blind, placebo-controlled phase 1\/2 clinical study","volume":"22","author":"Rowe","year":"2023","journal-title":"J. Cyst. Fibros."},{"issue":"8014","key":"10.1016\/j.jconrel.2025.114312_bb0350","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/s41586-024-07399-9","article-title":"A renewably sourced, circular photopolymer resin for additive manufacturing","volume":"629","author":"Machado","year":"2024","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2025.114312_bb0355","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijpharm.2007.11.005","article-title":"Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes","volume":"354","author":"Ishida","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"8009","key":"10.1016\/j.jconrel.2025.114312_bb0360","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/s41586-024-07266-7","article-title":"Interim analyses of a first-in-human phase 1\/2 mRNA trial for propionic acidaemia","volume":"628","author":"Koeberl","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.114312_bb0365","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02525","article-title":"Liver-mediated adaptive immune tolerance","volume":"10","author":"Zheng","year":"2019","journal-title":"Front. Immunol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925009265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925009265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:53:54Z","timestamp":1773158034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925009265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":73,"alternative-id":["S0168365925009265"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114312","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surface-engineered robust hybrid lipid nanocapsules: A next-generation nanoplatform for mRNA delivery","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114312","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114312"}}